Roche & Pathai Expand Digital Pathology for Diagnostics

Roche announced that it has signed an agreement with PathAI, a world leader in artificial intelligence (AI)-based pathology technologies.

Eris Lifesciences Buys 51% in Swiss Parenterals To Expand Sterile Injectables

Eris Lifesciences Ltd., an Indian marked plans organization, reported the extension of its Sterile Injectables impression through the securing of 51% value stake in Swiss Parenterals Ltd. for a thought of Rs.637.50 crore. As per a press...

Anixa Biosciences Initiates Second Ovarian Cancer CAR-T Trial Dosing

Anixa Biosciences, Inc., a clinical technology company focused on treating and preventing cancer, announced that it has started treatment for the fourth patient in its Phase 1 clinical trial of its novel T cell chimeric antigen receptor (CAR-T)

Supriya Life science Wins 8 Gold Awards at Maharashtra State Export Event

Supriya Life science Limited, a global leader in the manufacture of Active Pharmaceutical Ingredients (APIs), has achieved a major achievement by bagging the 8th Gold Award at the Maharashtra State

Mankind Pharma Partners with Lepra Society to Screen 80,000 for Leprosy

Mankind Pharma, an Indian pharmaceutical company, has announced a strategic partnership with the Lepra Society to launch a comprehensive campaign to eradicate, raise awareness, and cure leprosy.

DA Breakthrough Designation for AlphaMedix in Neuroendocrine Tumors

RadioMedix, Inc., a Houston-based clinical technology company and sponsor of the AlphaMedix clinical trial, and Orano Med, a clinical biotechnology company developing next-generation cancer therapies

EURO 2.7M Funding for Phase IIa Trials of CTH120 in Fragile X Syndrome

The public-private group, the biotechnology company CONNECT Therapeutics, the Genome Regulation Center (CRG), the Hospital del Mar Institute (IMIM) and the Parc Taulí Research and Innovation Institute (I3PT) received 2.7 million euros.

Racefor7 Returns: Raising Rare Disease Awareness Feb 25

ORDI (Organization for Rare Diseases of India) will hold its annual flagship conference Racefor7" It will be held in 15 cities across India on February 25.

FDA Fast Track for GSK's Bepirovirsen in Chronic Hepatitis

GSK plc announced that the US Food and Drug Administration (FDA) Fast Track designation for bepirovirsen, an antisense oligonucleotide (ASO) probe for the treatment of chronic hepatitis B (CHB).

Birla Hospital Upgrades OT with Saqsham's Premium Tower 7K for Arthroscopy

CK Birla Hospital, a multi-specialty hospital in Gurgaon sponsored by Saqsham Orthopedics, has installed the ArthroVIMS imaging system for surgeons in its Department of Arthroscopy and Sports Medicine.

© 2025 India Pharma Outlook. All Rights Reserved.